Global Inhalation & Nasal Spray Generic Drugs Market 2018 Major Players- Teva, Sandoz, Apotex and Akorn

Global Inhalation & Nasal Spray Generic Drugs Market 2018 Major Players- Teva, Sandoz, Apotex and Akorn

The Objective of the “Global Inhalation & Nasal Spray Generic Drugs Market” report is to depict the trends and upcoming for the Inhalation & Nasal Spray Generic Drugs industry over the forecast years. Inhalation & Nasal Spray Generic Drugs Market report data has been gathered from industry specialist/experts. Worldwide Inhalation & Nasal Spray Generic Drugs […]

The creeping problem of drug shortages

The creeping problem of drug shortages

Dozens of drugs are suddenly unavailable every year. In Canada, we read about shortages of Epipens, opioids and antibiotics and before that, it was saline. In India, it is anti-HIV drugs for children. The problem is global, but most Canadians notice only when their pharmacists cannot fill their prescriptions. Hyped reporting of individual shortages obscures […]

Inhalation & Nasal Spray Generic Drugs Market Analysis & Trends – Industry Forecast to 2023

Inhalation & Nasal Spray Generic Drugs Market Analysis & Trends – Industry Forecast to 2023

Global Inhalation & Nasal Spray Generic Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 tracks the major market events including product launches, technological developments, mergers and acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific […]

Opinion: Seniors needlessly exposed to health risks, addiction

Opinion: Seniors needlessly exposed to health risks, addiction

Jim Renacci, Opinion contributor Published 10:39 a.m. ET June 26, 2018 The FDA proposed a rule in 2013 that would fix a generic drug safety loophole by allowing the generic drugmakers to promptly update their safety warnings in response to new dangers. And if the drugmakers did not do so, the families harmed by the […]

Senators Grill HHS's Azar on Drug Price Cuts That Have Yet to Come

Senators Grill HHS's Azar on Drug Price Cuts That Have Yet to Come

Xconomy National —  When President Trump signed legislation last month allowing seriously ill patients the “right to try” unapproved drugs without FDA oversight, he voiced a bold prediction: Within two weeks, he said, drug companies would announce “voluntary massive drops in prices.” Asked for further detail, the Department of Health and Human Services (HHS) declined […]

The global pharmaceutical glass packaging market size is expected to reach USD 22.05 billion by 2025

The global pharmaceutical glass packaging market size is expected to reach USD 22.05 billion by 2025

NEW YORK, June 26, 2018 /PRNewswire/ — Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Product (Vials, Ampoules, Cartridges & Syringes), By Drug Type (Generic, Branded, Biologic), And Segment Forecasts, 2018 – 2025 Read the full report: https://www.reportlinker.com/p05445406 The global pharmaceutical glass packaging market size is expected to reach USD 22.05 billion […]

Can We Make Old Drugs Great Again? The Relevance Of Licensing Generics

Can We Make Old Drugs Great Again? The Relevance Of Licensing Generics

Throughout a drug’s life cycle, there is a continuous development of drug features and new uses beyond the initial or approved drug indication. Identifying new applications for existing drugs, a process also known as drug rediscovery, repositioning, or repurposing, may create alternative treatment options while bypassing costs and time involved with bringing a new drug […]

Azar back for more Senate questions on Trump drug plan

Azar back for more Senate questions on Trump drug plan

With help from David Pittman, Brianna Ehley, Eleanor Mueller and Joanne Kenen AZAR BACK FOR ROUND TWO OF SENATE QUESTIONS ON TRUMP DRUG PRICE AGENDA — The HHS secretary is set to return to the Hill on Tuesday for a Senate Finance Committee hearing on challenges addressing prescription drug affordability and innovation. Azar testified about […]